Risk Factors that Impact Treatment with Oral Janus Kinase Inhibitors Among Adult Patients with Atopic Dermatitis: A Nationwide Registry Study
The European Medicines Agency recently limited the use of oral Janus kinase inhibitors in certain patient populations, including those with atopic dermatitis. This cross-sectional study used the Danish national registers and Danish Skin Cohort to assess the prevalence of risk factors that potentiall...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medical Journals Sweden
2024-01-01
|
| Serier: | Acta Dermato-Venereologica |
| Fag: | |
| Online adgang: | https://medicaljournalssweden.se/actadv/article/view/18638 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
